Cardiomyopathy Does Not Exacerbate the Severity of Pneumonia Caused by a SARS-CoV-2 Delta Variant in the J2N-k Hamster Model

Author:

Iwatsuki-Horimoto Kiyoko12,Ito Mutsumi1,Okuda-Hamabata Moe1,Takagi Hisayoshi3,Imai Masaki14,Kawaoka Yoshihiro12456

Affiliation:

1. Division of Virology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan

2. Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), University of Tokyo, Minato-ku, Tokyo 108-8639, Japan

3. Japan SLC, Inc., Hamamatsu, Shizuoka 433-8114, Japan

4. The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Shinjuku-ku, Tokyo 162-8655, Japan

5. Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan

6. Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, WI 53711, USA

Abstract

Cardiovascular disease is one of many risk factors that have been linked to increased severity or mortality in coronavirus disease 2019 (COVID-19) patients; however, the exact role of SARS-CoV-2 in the pathogenesis of cardiac inflammatory injury has not been established. A previous study reported that SARS-CoV-2 causes more severe disease with cardiomyopathy in a J2N-k animal model. Here, we investigated the sensitivity of J2N-k hamsters, as a cardiomyopathy animal model, to a delta strain of SARS-CoV-2 compared to J2N-n control animals. We found that J2N-k hamsters were less susceptible to this delta strain than J2N-n animals, and we found no evidence that cardiomyopathy is a risk factor in this animal model. Since the previous study reported that SARS-CoV-2 causes more severe disease with cardiomyopathy in the same animal model, further analysis of the relationship between cardiomyopathy and SARS-CoV-2 infection is needed.

Funder

Japan Program for Infectious Diseases Research and Infrastructure

Japan Agency for Medical Research and Development

Publisher

MDPI AG

Subject

Virology,Infectious Diseases

Reference31 articles.

1. World Health Organization (2023, October 13). Naming the Coronavirus Disease (COVID-19) and the Virus that Causes It. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it.

2. Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis;Noor;J. Community Health,2020

3. Risk factors for severe and critically ill COVID-19 patients: A review;Gao;Allergy,2021

4. COVID-19 and Cardiovascular Disease: A Global Perspective;Pina;Curr. Cardiol. Rep.,2021

5. COVID-19 and cardiovascular disease: A review of current knowledge;Pal;Horm. Mol. Biol. Clin. Investig.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3